Evidence map›Paper›PMID 31036086›Full record

ArticleActa neuropathologica communications2019

Drosophila Ref1/ALYREF regulates transcription and toxicity associated with ALS/FTD disease etiologies.

Amit Berson, Lindsey D Goodman, Ashley N Sartoris, Charlton G Otte, James A Aykit, Virginia M-Y Lee, John Q Trojanowski, Nancy M Bonini

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Article
  16. Article
  17. Modeling Neurodegenerative Disorders inInternational journal of molecular sciences · 2020
    Review
  18. The Role of Lozenge inMolecules and cells · 2020
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Amit BersonDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Lindsey D GoodmanNeuroscience Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Ashley N SartorisDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Charlton G OtteDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
James A AykitDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Virginia M-Y LeeDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
John Q TrojanowskiDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Nancy M BoniniDepartment of Biology, University of Pennsylvania, Philadelphia, PA, 19104, USA. nbonini@sas.upenn.edu.ORCID 0000-0003-0226-5291
University of Pennsylvania · US

Funding

Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
SYSTEMS AND INTEGRATIVE BIOLOGYT32GM007517 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GOLD, JOSHUA I · 1985 to 2017
$8.0M
Molecular Genetic Insight into Neurodegenerative Disease from DrosophilaR35NS097275 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BONINI, NANCY M · 2017 to 2024
$6.0M
Examining neuronal resilience in a mouse model of sporadic ALSR01NS110688 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2019 to 2023
$1.8M
Epigenetic mechanisms of TDP43-mediated neurodegenerationF32NS084667 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BERSON, AMIT · 2013 to 2015
$159k
NIA NIH HHS P01 AG017586NIGMS NIH HHS T32 GM007517NINDS NIH HHS F32 NS084667NINDS NIH HHS R01 NS110688NINDS NIH HHS R35 NS097275
6 · The paper itself

Abstract

RNA-binding proteins (RBPs) are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but the underlying disease mechanisms remain unclear. In an unbiased screen in Drosophila for RBPs that genetically interact with TDP-43, we found that downregulation of the mRNA export factor Ref1 (fly orthologue to human ALYREF) mitigated TDP-43 induced toxicity. Further, Ref1 depletion also reduced toxicity caused by expression of the C9orf72 GGGGCC repeat expansion. Ref1 knockdown lowered the mRNA levels for these related disease genes and reduced the encoded proteins with no effect on a wild-type Tau disease transgene or a control transgene. Interestingly, expression of TDP-43 or the GGGGCC repeat expansion increased endogenous Ref1 mRNA levels in the fly brain. Further, the human orthologue ALYREF was upregulated by immunohistochemistry in ALS motor neurons, with the strongest upregulation occurring in ALS cases harboring the GGGGCC expansion in C9orf72. These data support ALYREF as a contributor to ALS/FTD and highlight its downregulation as a potential therapeutic target that may affect co-existing disease etiologies.

Indexed as

Gene Expression RegulationAmyotrophic Lateral SclerosisAnimalsDNA-Binding ProteinsDown-RegulationDrosophilaDrosophila ProteinsFemaleFrontotemporal DementiaHumansMaleMotor NeuronsNuclear ProteinsRNA-Binding ProteinsRNA, MessengerTranscription FactorsALYREF protein, humanDNA-Binding ProteinsDrosophila ProteinsNuclear ProteinsRNA-Binding ProteinsRNA, MessengerTBPH protein, DrosophilaTranscription FactorsALYREFAmyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)Ataxin-2C9orf72DrosophilamRNANeurodegenerationNuclear transportRef1TAR DNA-binding protein 43 (TDP-43) (TARDBP)

Identifiers

PMID31036086
PMCPMC6487524
OpenAlexW2947370842

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.